The Prevention Of Heart Diseases With An Extra Injection Of Insulin After Meals In Patients With Type 1 Diabetes
The earlier studies show that ten times enhanced the risk of cardiovascular disease in patients with type 1 diabetes (T1D). A current study at Newcastle University, the United Kingdom shows the protection against heart disease and cardiovascular disease with an extra or one-third of normal insulin dose, three hours after taking a high-fat meal.
In general, insulin dosage will be calculated with the number of carbohydrates present in the meal. But experts say that this method to calculate insulin does not account the fat in the meal. The body can take more time to metabolize (a chemical process in the body where food changes into energy) fats when compared with carbohydrates.
A patient with type 1 diabetes (T1D) may struggle to normalize the blood sugar (glucose) level with the fat meal as the standard insulin dose may leave the bloodstream or insulin dose may have lost its power. The high level of sugar (glucose) and fat in the bloodstream and inflammatory blood markers can increase the risk of cardiovascular diseases.
The researchers have conducted a trial at the NIHR Newcastle Clinical Research Facility, Newcastle University, the United Kingdom on ten patients with type 1 diabetes (T1D). The participants ate three meals per day with identical protein and carbohydrate content.
The trial has found an elevated blood sugar (glucose) level in the participants, even after six hours with the consumption of a high-fat diet with a standard insulin dosage. But the study has found a normal blood sugar (glucose) level with an extra or one-third of normal insulin dosage, three hours after the high-fat meal.
But the researchers say that patients should consult the doctor and should take their advice before altering the insulin dosage and timing.
Now, the researchers are planning to conduct a long-term trial with more patients.
The co-authors of the study are Dr. Matthew Campbell, the Leeds Beckett University, Leeds, the United Kingdom and Dr. Daniel West, the Newcastle University, the United Kingdom. The study was published on March 21, 2017, in the journal Diabetes and Vascular Disease Research. Title of the article is "An additional bolus of rapid-acting insulin to normalize postprandial cardiovascular risk factors following a high-carbohydrate high-fat meal in patients with type 1 diabetes: A randomised controlled trial."
Cancer, Diabetes And Heart Diseases Can Be Protected By Eating Red Onions
Red onions are part of the Mediterranean diet. A study by researchers at the University of Guelph, Canada shows the prevention of cancer and destruction of the tumour (or tumor) cells by eating plenty of red onion.
Red onions are rich in chemicals, anti-cancer compounds, anthocyanins and quercetin. The researchers have found that red onions are good in killing the cancer cells and they activate pathways that support the death of the cancer cells. They also disrupt the growth-oriented communication between cancer cells by promoting an unfavorable environment.
A study on five types of onions in Ontario (a province in east-central Canada) has found that the ruby ring red onion variety has cancer-fighting (anti-cancer) properties. The researchers are thinking that the addition of onion extract in food products and in a pill form (anti-cancer drug or therapy) can naturally prevent cancer. But the best way is to consume red onion is in the raw form. The following are the other advantages with red onions.
The lead author of the study was Abdulmonem Murayyan, a Ph.D., student and Professor Suresh Neethirajan, the University of Guelph, Ontario, Canada. The study was published in June 2017 in the Food Research International. Title of the article is "Antiproliferative activity of Ontario grown onions against colorectal adenocarcinoma cells"
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.